Wiktionary
sifalimumab
n. A human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
Wikipedia
Sifalimumab
Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a.
Sifalimumab was developed by MedImmune.